Penicillin: observation was not yet a medicine
In 1928, Alexander Fleming observed that a mould inhibited bacterial growth. This is a central milestone in the story of penicillin, but it is not the same as having a stable, widely available treatment. Turning the observation into an effective medicine required further experimental work, purification, clinical investigation and large-scale production.
Howard Florey, Ernst Boris Chain and their collaborators played crucial roles in that development. Fleming, Chain and Florey shared the 1945 Nobel Prize in Physiology or Medicine for the discovery of penicillin and its curative effect in infectious diseases. The shared award itself points beyond the familiar story of a lone scientist and a fortunate laboratory accident.
The evidence question changes at each stage. An observation can suggest that a substance affects bacteria. Laboratory experiments investigate that effect under controlled conditions. Treatment claims require evidence about patients, dose, safety and outcomes. Industrial production then raises separate questions of consistency and supply.
DNA: a structure is not a complete sequence
In 1953, James Watson and Francis Crick published a double-helix model for DNA. The work drew on chemical reasoning and experimental evidence, including X-ray diffraction research associated with Rosalind Franklin, Raymond Gosling, Maurice Wilkins and colleagues. A defensible short account should not turn a collaborative and contested history into a two-name invention story.
The model helped explain how genetic information could be organized and copied. It did not identify every base in the human genome. Watson, Crick and Wilkins received the 1962 Nobel Prize in Physiology or Medicine; Franklin, who died in 1958, was not a recipient. The award list is a record of recognition, not a complete list of contributors.
The Human Genome Project’s completion announcement in 2003 marked another kind of milestone: a high-quality human reference sequence covering the great majority of gene-containing regions. It did not mean that every difficult region had been fully resolved. In 2022, the Telomere-to-Telomere Consortium reported a complete sequence of a human genome assembly, addressing major gaps in the earlier reference. That assembly did not capture all human genetic variation.
Gravitational waves: detecting a signal is a dated event
On 14 September 2015, the two LIGO detectors recorded the signal known as GW150914. The result was announced on 11 February 2016 and described in a peer-reviewed paper. It provided the first direct detection of gravitational waves and evidence of a binary black-hole merger.
The instrument does not photograph black holes colliding. Laser interferometers measure extremely small changes in the relative lengths of perpendicular arms. Researchers compare the observed signal with physical models, examine noise and instrumental behaviour, and test whether an ordinary disturbance could explain the event.
“First direct detection” is a deliberate qualifier. Earlier observations of binary pulsars had provided important indirect evidence consistent with gravitational-wave emission. LIGO’s achievement did not erase that earlier work; it established a different observational capability.
Dates that answer different questions
- 1928 and 1945. A penicillin observation and later Nobel recognition mark different stages.
- 1953, 2003 and 2022. A molecular model, a genome-project milestone and a more complete assembly are not competing dates for the same event.
- 2015 and 2016. The gravitational-wave signal was recorded before the public announcement and publication.
Scientific confidence is not established by a famous name or an award alone. Methods, data, calibration, alternative explanations and subsequent scrutiny carry the explanatory weight. A later refinement can improve an earlier account without making the earlier achievement meaningless.
For a new claim, ask what was directly observed, what was inferred and what the authors say remains uncertain. Then distinguish the original research from press coverage and retrospective summaries. The breakthrough is often more impressive when its limits are described honestly.